1182331

Source:http://linkedlifedata.com/resource/pubmed/id/1182331

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013185, umls-concept:C0220905, umls-concept:C0449911, umls-concept:C0683966, umls-concept:C0851285
pubmed:issue	5
pubmed:dateCreated	1976-1-14
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7505404
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Asbestos
pubmed:status	MEDLINE
pubmed:issn	0048-2986
pubmed:author	pubmed-author:NewmarkHH
pubmed:issnType	Print
pubmed:volume	29
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	218-21
pubmed:dateRevised	2000-12-18
pubmed:meshHeading	pubmed-meshheading:1182331-Asbestos, pubmed-meshheading:1182331-Drug Industry, pubmed-meshheading:1182331-Legislation, Drug, pubmed-meshheading:1182331-United States, pubmed-meshheading:1182331-United States Food and Drug Administration
pubmed:articleTitle	II. Views of the pharmaceutical industry on the regulations.
pubmed:publicationType	Journal Article